Rituximab or plasmapheresis for prevention of recurrent focal segmental glomerulosclerosis after kidney transplantation: A systematic review and meta-analysis

BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is one of the most common glomerular diseases leading to renal failure. FSGS has a high risk of recurrence after kidney transplantation. Prevention of recurrent FSGS using rituximab and/or plasmapheresis has been evaluated in multiple small studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonpheng, Boonphiphop, Hansrivijit, Panupong, Thongprayoon, Charat, Mao, Shennen A, Vaitla, Pradeep K, Bathini, Tarun, Choudhury, Avishek, Kaewput, Wisit, Mao, Michael A, Cheungpasitporn, Wisit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291000/
https://www.ncbi.nlm.nih.gov/pubmed/34316454
http://dx.doi.org/10.5500/wjt.v11.i7.303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291000/
https://www.ncbi.nlm.nih.gov/pubmed/34316454
http://dx.doi.org/10.5500/wjt.v11.i7.303

Ejemplares similares